All Pharma News
Aldeyra Highlights Preclinical Data, Announces Pivotal RP Trial Plan

Aldeyra Highlights Preclinical Data, Announces Pivotal RP Trial Plan
BUSINESSWIRE
25 Apr 2024
Share Share
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024

Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
BUSINESSWIRE
18 Apr 2024
Share Share
Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease

Aldeyra Therapeutics Announces Clinical Development Plan for Resubmission of New Drug Application for Reproxalap in Dry Eye Disease
PRESS RELEASE
29 Mar 2024
Share Share
Aldeyra Therapeutics Provides Clinical and Regulatory Update

Aldeyra Therapeutics Provides Clinical and Regulatory Update
BUSINESSWIRE
04 Jan 2024
Share Share
ADC Tx, Aldeyra leave programs behind in 2023

ADC Tx, Aldeyra leave programs behind in 2023
Gabrielle Masson FIERCE BIOTECH
04 Jan 2024
Share Share
Aldeyra Therapeutics` skin disease drug succeeds in mid-stage study

Aldeyra Therapeutics` skin disease drug succeeds in mid-stage study
REUTERS
19 Dec 2023
Share Share
Aldeyra Therapeutics Schedules Conference Call and Webcast

Aldeyra Therapeutics Schedules Conference Call and Webcast
BUSINESSWIRE
18 Dec 2023
Share Share
Aldeyra Receives CRL from FDA for the Reproxalap NDA for Dry Eye Disease

Aldeyra Receives CRL from FDA for the Reproxalap NDA for Dry Eye Disease
BUSINESSWIRE
28 Nov 2023
Share Share
Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie

Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie
BUSINESSWIRE
01 Nov 2023
Share Share
AbbVie seeks Restasis follow-up with small option fee for Aldeyra’s eye drops

AbbVie seeks Restasis follow-up with small option fee for Aldeyra’s eye drops
Kyle LaHucik ENDPTS
01 Nov 2023
Share Share